Compositions for the treatment of peripheral ulcers of various origins

a technology of compositions and ulcers, applied in the field of compositions for the treatment of ulcers of various origins, can solve problems such as difficult healing of ulcers

Active Publication Date: 2013-09-12
INDENA SPA
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The inventors have developed new materials that can stimulate cells from different parts of our body's own blood vessels for better healing after surgery on damaged areas like those causing painful wounds. These agents include both vasoactive compound (catechol) and substances called cytokinin. They are also used against viruses including herpes virus types 1-4 and influenza type 3). This material helps reduce swelling around affected tissues while promoting faster recovery time during rehabilitation procedures.

Problems solved by technology

This patented technical problem addressed in this patents relates to various types of disordered conditions such as perforations (permanence) around blood vessels called vein valves), leg weaknesses, fissures, burn injuries, pressure sore feet, etc., causing damage for patients who use these devices frequently during their lifetime. These issues lead to difficulties in achieving proper treatment through conventional methods involving antibiotic therapy alone or surgery techniques.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

preparation examples

Example 1

Preparation of Aesculus Hippocastanum Bark Extract

[0033]Procyanidin A2 and esculoside are repeatedly extracted from 5 Kg of bark from finely ground Aesculus hippocastanum branches with 95% ethanol until exhausted. The extraction solvent is concentrated to an equal weight with the starting biomass, and the concentrate is filtered to eliminate undesirable substances. The filtrate is concentrated until dry under vacuum at a temperature not exceeding 40° C. 570 g of a beige extract with a 35% esculoside content and an 11.2% procyanidin A2 is obtained. This extract can be used “as is” in the formulations according to the invention.

example 2

Preparation of Echinacea Angustifolia Root Extract

[0034]Echinacoside, caffeoylquinic acids and isobutylamides are extracted from 2 Kg of finely ground Echinacea angustifolia roots with 95% ethanol at the temperature of 50° C. until exhausted. Thin-layer chromatography is used to test for exhaustion, with echinacoside as the marker. The extraction solvent is concentrated under vacuum at a temperature of 25° C., taking care not to distil the basic oil containing the isobutylamides in steam current. By concentrating the solvent until dry, 150 g of extract with a 4% echinacoside content and an 0.5% isobutylamide content is obtained. This extract can be used “as is” in the formulations according to the invention.

PHARMACOLOGICAL EXAMPLE

example 3

Effect on Ulcers Caused by Venous Stasis of the Lower Limbs

[0035]50 patients (10 per group), suffering from venous stasis ulcers of the lower limbs, not complicated by other vascular disorders, were included in the study.

[0036]The patients were treated with the preparation described in example 7, applied to the lesion twice a day. The treated lesions were then covered with a bandage to ensure that the cream was not removed, and to protect them against external agents and / or mechanical traumas. The lesions were monitored for 21 days, and re-epithelialisation was assessed by measuring the two diameters. The results were expressed as the mean of the two diameters measured.

[0037]The results are set out in the table below.

RE-EPITHELIALISATIONTREATMENT7 days14 days28 daysPlacebo0.02 V 0.010.01 ± 0.010.03 ± 0.02Preparation example 72.14 ± 0.73** 4.9 ± 1.01**8.30 ± 1.10**Placebo + Vaccinium0.10 ± 0.030.23 ± 0.13*0.50 ± 0.23*myrtillus 0.3%Placebo + Echinacea0.01 ± 0.010.20 ± 0.02*0.35 ± 0.02*

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Login to view more

Abstract

The present invention relates to compositions containing a combination of a cell proliferation-stimulating agent with vasokinetic properties and an antimicrobial, antifungal and antiviral agent with an anti-inflammatory/analgesic, which is useful in the treatment of peripheral ulcers of various origins, such as diabetic ulcers, ulcers caused by venous stasis of the limbs, bedsores and the associated skin infections. Said combination could be presented as formulations for topical or systemic use.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner INDENA SPA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products